EMA veterinary medicines innovation day Thursday, 19 April 2018 European Medicines Agency London, United Kingdom

About this event The objective of this meeting is to further raise awareness of the support available to facilitate innovation of veterinary medicines by giving an overview of the legislative framework and by describing the support offered by the EMA and interactions with stakeholders. This event is open to all companies and stakeholders developing veterinary medicinal products.

Arrival at the Agency and registration On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry lounge is located through the sliding doors to the right of the reception desk past the security turnstiles. Your EMA contact point will meet you there. We strongly advise you to arrive up to 30 minutes before the start of the info day, to allow you time for registration. Please note that the Agency requires all visitors to provide a valid photo ID on arrival, such as passport, identity card or driving licence. Participants without a valid photo ID may be turned away.

Media disclaimer The Agency records or broadcasts a number of its meetings, including some virtual meetings. This is part of the Agency’s commitment to the principle of transparency as enshrined in the Treaty on European Union. The Agency herewith informs attendees that this particular meeting will be recorded and broadcast. For more information about processing of personal data by EMA, please visit the EMA website or contact: [email protected] By attending this meeting you consent to any recording or broadcast.

Venue European Medicines Agency 30 Churchill Place Canary Wharf, London E14 5EU United Kingdom

Telephone +44 (0)20 3660 7099 E-mail: [email protected] Website: www.ema.europa.eu

EMA veterinary medicines innovation day - Agenda 13:30-17:45, Meeting Room: 3A and 3M 1.

Registration / 13:00-13:30 Chair: I. Claassen, Head of EMA Veterinary Division Welcome and opening remarks / 13:30-13:40 Session 1: EU legislative framework for veterinary medicinal products

2.

EC perspective on innovation in veterinary medicinal product development Impact of new veterinary regulation in innovation Speaker: C. Siebert, EC / 13:40-14:10

3.

Promoting innovation through the veterinary regulatory framework: Role of EMA

4.

Questions and answers / 14:30-14:40

Speaker: D. Mackay, EMA / 14:10-14:30

Session 2: EMA interactions to support innovative medicines 5.

Introduction to SME incentives

6.

Advantages of Minor Use Minor Species (MUMS) classification to innovative products

7.

Innovation Task Force and ITF briefing meetings: What can be gained

Speaker: H. Casaert, EMA / 14:40-14:55

Speaker: M. Jakava-Viljanen, EMA / 14:55-15:10

Speaker: M. Leppänen, EMA / 15:10-15:25

8.

How scientific advice procedure can support innovation

9.

Questions and answers / 15:40-15:55

Speaker: R. Breathnach, CVMP, SAWP-V Chair / 15:25-15:40

Break / 15:55-16:15 Chair: David Murphy, CVMP Session 3: Interactions with Stakeholders 10. EMA –Academia collaboration framework Speaker: M. Ensini, EMA / 16:15-16:30

11. Role of ADVENT in innovation support

Speaker: E. Werner, CVMP, ADVENT, IWP Chair / 16:30-16:45

12. Stakeholder interaction in EMA innovation support Speaker: I. Claassen, EMA / 16:45-17:00

13. Experience of EMA innovation support from a stakeholder perspective

Speakers: S. Arnouts, PROVAXS – Ghent University; A.Pradera, Equicord Ymas S.L. / 17:00-17:20

14. AMEG’s proposal for an Early Hazard Characterisation to encourage the development of novel antimicrobial VMPs Speaker: H. Jukes, CVMP vice-chair. AWP chair / 17:20-17:30

15. Questions and answers / 17:30-17:45 Closing remarks by chairs / 17:45 On 20 April 2018, the European Medicines Agency will give an update on Brexit regulatory preparedness activities during another session organised for veterinary companies. Participants attending the Innovation Day will also be welcome at this meeting.

www.ema.europa.eu/vet

Agenda - European Medicines Agency veterinary medicines ...

On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry lounge is located through the sliding doors to the right of the reception desk past.

476KB Sizes 0 Downloads 467 Views

Recommend Documents

Agenda - European Medicines Agency veterinary medicines info day
Send a question via our website www.ema.europa.eu/contact. © European Medicines ... Innovation: How to make legislation more supportive for innovation (15').

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

Agenda - European Medicines Agency - Europa EU
Dec 7, 2016 - publication of clinical data (Policy 0070) and revisions to the guidance to industry – Industry Associations Webinar. 9 December 2016, 10:00 to ...

Veterinary pharmacovigilance 2016 - European Medicines Agency
Feb 16, 2017 - monitoring of several centrally authorised products ..... regulatory tools within the EU that are ... Following to this, a Rapid alert was circulated.

Agenda - European Medicines Agency - Europa EU
Sep 19, 2017 - 14:00-14:05. 2. Data integrity – early signal detection. - data patterns/trends in data ... 16:20-17:00. 5. Inspections of Ligand Binding Assays (in.

Agenda - European Medicines Agency - Europa EU
Nov 7, 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone ...... Visualisation of choline metabolism in malignant neoplasms ..... A paediatric investigation plan (PIP) is a dev

Agenda - European Medicines Agency - Europa EU
Jan 23, 2018 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes listed against products, it must be

Agenda - European Medicines Agency - Europa EU
Oct 24, 2017 - Application of Article 8(2) of the Orphan Regulation ..... propoxy)-phenyl]-methanone, EMA/OD/187/14 Herpes simplex type 1 virus containing.

Agenda - European Medicines Agency - Europa EU
Jun 14, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... EMA initiatives to support and accelerate early access. 10:00 2.1 ...

Agenda - Patient Registries Workshop - European Medicines Agency
Oct 18, 2016 - Send a question via our website www.ema.europa.eu/contact ... marketing authorisation holder (MAH) to create a new registry based on a ...

Agenda - European Medicines Agency - Europa EU
6 days ago - EMA/OD/103/14 Donor T lymphocytes depleted ex vivo of host alloreactive T cells using photodynamic treatment, EMA/OD/175/14 Allogeneic ...

Agenda - European Medicines Agency - Europa EU
o Pilot to test draft model ... Endorsement of Enpr-EMA membership criteria Mark Turner/Irmgard. Eichler ... Endorsement of newly received applications.